Evidence map›Paper›PMID 41969632›Full record

ArticleMedComm2026

Ipriflavone From

Dezhi Wang, Xingchen Liao, Yilin Wang, Xuexin Wang, Heng Zhang, Jie Zeng, Mingjie Zhang, Xin Wang, Fangli Ren, Yinyin Wang and 6 more

Abstract read
In one paragraph

Article in MedComm, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Dezhi WangMedical School of Chinese PLA Chinese PLA General Hospital Beijing China.
Xingchen LiaoMedical School of Chinese PLA Chinese PLA General Hospital Beijing China.
Yilin WangMedical School of Chinese PLA Chinese PLA General Hospital Beijing China.
Xuexin WangMedical School of Chinese PLA Chinese PLA General Hospital Beijing China.
Heng ZhangMedical School of Chinese PLA Chinese PLA General Hospital Beijing China.
Jie ZengDepartment of Urology The Second Affiliated Hospital, School of Medicine South China University of Technology Guangzhou China.
Mingjie ZhangDepartment of Gastroenterology The Seventh Medical Center of Chinese PLA General Hospital Beijing China.
Xin WangDepartment of Gastroenterology The Seventh Medical Center of Chinese PLA General Hospital Beijing China.
Fangli RenState Key Laboratory of Membrane Biology School of Medicine Institute of Precision Medicine Tsinghua University Beijing China.
Yinyin WangState Key Laboratory of Membrane Biology School of Medicine Institute of Precision Medicine Tsinghua University Beijing China.
Meng LiState Key Laboratory of Membrane Biology School of Medicine Institute of Precision Medicine Tsinghua University Beijing China.
Wenchen WangSchool of Medicine Nankai University Tianjin China.
Qing LinDepartment of Anesthesiology and Critical Care Medicine School of Medicine Johns Hopkins University Baltimore Maryland USA.
Lingyun GuSenior Department of TCM The Sixth Medical Center of Chinese PLA General Hospital Beijing China.
Zhijie ChangState Key Laboratory of Membrane Biology School of Medicine Institute of Precision Medicine Tsinghua University Beijing China.
Jianqiu ShengMedical School of Chinese PLA Chinese PLA General Hospital Beijing China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The major challenge in the clinical treatment of gastrointestinal mucosal injury caused by high-altitude hypoxic environments lies in its unclear underlying mechanisms. In the previous study, we found that hypoxia-induced gastric and small intestinal damage was mainly attributable to ferroptosis mediated by hypoxia-inducible factor-α (HIF-α; mainly HIF-1α and HIF-2α). Both plant exosome-like nanoparticles and

Indexed as

Aquilaria malaccensis Lam. exosome‐like nanoparticles (AELNs)ferroptosishypoxiahypoxia‐inducible factor‐α (HIF‐α)ipriflavoneprolyl hydroxylase domain protein 2 (PHD2)

Identifiers

PMID41969632
PMCPMC13066503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.